Jupiter Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-46,745
Closed -$11.5M 597
2022
Q3
$11.5M Buy
46,745
+3,705
+9% +$1M 0.18% 161
2022
Q2
$10.7M Buy
+43,040
New +$11.6M 0.15% 176
2021
Q4
Sell
-1,749
Closed -$569K 665
2021
Q3
$569K Sell
1,749
-17,713
-91% -$6M 0.01% 461
2021
Q2
$6.07M Sell
19,462
-49,154
-72% -$15.1M 0.06% 268
2021
Q1
$21.9M Sell
68,616
-5,658
-8% -$1.81M 0.22% 135
2020
Q4
$24.1M Buy
74,274
+23,549
+46% +$6.51M 0.24% 117
2020
Q3
$14M Buy
50,725
+31,263
+161% +$9.01M 0.15% 164
2020
Q2
$4.7M Hold
19,462
0.16% 139
2020
Q1
$2.82M Buy
+19,462
New +$3.23M 0.12% 152

Other funds holding ABMD

Jupiter Asset Management's ABMD Position: Q4 2022 in Review

Jupiter Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 46,745 shares — an estimated $11.5M sold.

Jupiter Asset Management first reported a position in ABMD in Q1 2020 and held it in 9 quarters. The position peaked at $24.1M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Jupiter Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Jupiter Asset Management sold 46,745 Abiomed Inc shares in Q4 2022, an estimated $11.5M.
  • Jupiter Asset Management first reported a position in Abiomed Inc in Q1 2020 and held it in 9 quarters.
  • Jupiter Asset Management's Abiomed Inc position peaked at $24.1M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Jupiter Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.